Decreased annexin A3 expression correlates with tumor progression in papillary thyroid cancer

Proteomics - Clinical Applications

Volumn 4, Issue 5, 2010, Pages 528-537

  Jung, Eun Jung ^a,b   Moon, Hyeong Gon ^a,b   Park, Soon Tae ^a,b   Cho, Bok Im ^a   Jeong, Sun Min Lee ^a,b   Ju, Young Tae ^a,b   Jeong, Sang Ho ^a,b   Lee, Young Joon ^a,b   Choi, Sang Kyung ^a,b   Ha, Woo Song ^a,b   Lee, Jong Sil ^b   Kang, Kee Ryeon ^b   Hong, Soon Chan ^a,b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

ANXA3; Papillary thyroid carcinoma; Protein marker; Tumor progression

Indexed keywords

GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER SIZE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE CANCER; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; THYROID CANCER; VALIDATION STUDY; WESTERN BLOTTING;

ADENOCARCINOMA, PAPILLARY; ANNEXIN A3; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; LYMPHATIC METASTASIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953867686     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900063     Document Type: Article

References (29)

1. Parker, S. L., Tong, T., Bolden, S., Wingo, P. A., Cancer statistics, 1997. CA Cancer J. Clin. 1997, 47, 5-27.
2. Schlumberger, M. J., Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 1998, 338, 297-306.
3. Gerke, V., Moss, S. E., Annexins: from structure to function. Physiol. Rev. 2002, 82, 331-371.
4. Hayes, M. J., Moss, S. E., Annexins and disease. Biochem. Biophys. Res. Commun. 2004, 322, 1166-1170.
5. Lim, L. H., Pervaiz, S., Annexin 1: the new face of an old molecule. FASEB J. 2007, 21, 968-975.
6. Rand, J. H., The annexinopathies: a new category of diseases. Biochim. Biophys. Acta 2000, 1498, 169-173.
7. Mussunoor, S., Murray, G. I., The role of annexins in tumour development and progression. J. Pathol. 2008, 216, 131-140.
8. Harashima, M., Harada, K., Ito, Y., Hyuga, M. et al., Annexin A3 expression increases in hepatocytes and is regulated by hepatocyte growth factor in rat liver regeneration. J. Biochem. 2008, 143, 537-545.
9. Park, J. E., Lee, D. H., Lee, J. A., Park, S. G. et al., Annexin A3 is a potential angiogenic mediator. Biochem. Biophys. Res. Commun. 2005, 337, 1283-1287.
10. Liu, Y. F., Xiao, Z. Q., Li, M. X., Li, M. Y. et al., Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J. Pathol. 2009, 217, 54-64.
11. Wozny, W., Schroer, K., Schwall, G. P., Poznanovic, S. et al., Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: cancer association of annexin A3. Proteomics 2007, 7, 313-322.
12. Giusti, L., Iacconi, P., Ciregia, F., Giannaccini, G. et al., Fineneedle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J. Proteome Res. 2008, 7, 4079-4088.
13. Ou, K., Yu, K., Kesuma, D., Hooi, M. et al., Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. J. Proteome Res. 2008, 7, 1518-1528.
14. Pei, H., Zhu, H., Zeng, S., Li, Y. et al., Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J. Proteome Res. 2007, 6, 2495-2501.
15. Dai, Z., Liu, Y. K., Cui, J. F., Shen, H. L. et al., Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics 2006, 6, 5857-5867.
16. Bai, X. F., Ni, X. G., Zhao, P., Liu, S.M. et al., Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J. Gastroenterol. 2004, 10, 1466-1470.
17. Duncan, R., Carpenter, B., Main, L. C., Telfer, C., Murray, G. I., Characterisation and protein expression profiling of annexins in colorectal cancer. Br. J. Cancer 2008, 98, 426-433.
18. van Baal, J. W., Milana, F., Rygiel, A. M., Sondermeijer, C. M. et al., A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma. Cell Oncol. 2008, 30, 63-75.
19. Hu, N., Flaig, M. J., Su, H., Shou, J. Z. et al., Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin. Cancer Res. 2004, 10, 6013-6022.
20. Paweletz, C. P., Ornstein, D. K., Roth, M. J., Bichsel, V. E. et al., Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 2000, 60, 6293-6297.
21. Wu, C. M., Lee, Y. S., Wang, T. H., Lee, L. Y. et al., Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray. Oncol. Rep. 2006, 15, 57-64.
22. Garcia Pedrero, J. M., Fernandez, M. P., Morgan, R. O., Herrero Zapatero, A. et al., Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am. J. Pathol. 2004, 164, 73-79.
23. Kang, J. S., Calvo, B. F., Maygarden, S. J., Caskey, L. S. et al., Dysregulation of annexin I protein expression in highgrade prostatic intraepithelial neoplasia and prostate cancer. Clin. Cancer Res. 2002, 8, 117-123.
24. Shen, D., Nooraie, F., Elshimali, Y., Lonsberry, V. et al., Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum. Pathol. 2006, 37, 1583-1591.
25. Hsiang, C. H., Tunoda, T., Whang, Y. E., Tyson, D. R., Ornstein, D. K., The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 2006, 66, 1413-1424.
26. Kessler, C., Junker, H., Balseanu, T. A., Oprea, B. et al., Annexin A3 expression after stroke in the aged rat brain. Rom. J. Morphol. Embryol. 2008, 49, 27-35.
27. Netea-Maier, R. T., Hunsucker, S. W., Hoevenaars, B. M., Helmke, S. M. et al., Discovery and validation of protein abundance differences between follicular thyroid neoplasms. Cancer Res. 2008, 68, 1572-1580.
28. Kollermann, J., Schlomm, T., Bang, H., Schwall, G. P. et al., Expression and prognostic relevance of annexin A3 in prostate cancer. Eur. Urol. 2008, 54, 1314-1323.
29. Madoz-Gurpide, J., Lopez-Serra, P., Martinez-Torrecuadrada, J. L., Sanchez, L. et al., Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis. Mol. Cell. Proteomics 2006, 5, 1471-1483.